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Potassium channelSAP97 is a member of the MAGUK family of proteins that play a major role in the trafﬁcking and targeting of
membrane ion channels and cytosolic structural proteins in multiple cell types. Within neurons, SAP97 is local-
ised throughout the secretory trafﬁcking pathway and at the postsynaptic density (PSD). SAP97 differs from
other MAGUK family members largely in its long N-terminus and in the sequences between the SH3 and
GUK domains, where SAP97 undergoes signiﬁcant alternative splicing to produce multiple SAP97 isoforms.
These splice insertions endow SAP97 with differential cellular localisation patterns and functional roles within
neurons. With regard to membrane ion channels, SAP97 forms multi-protein complexes with AMPA and
NMDA-type glutamate receptors, and Kv1.4, Kv4.2, and Kir2.2 potassium channels, playing a major role in traf-
ﬁcking and anchoring ion channel surface expression. This highlights SAP97 not only as a regulator of neuronal
excitability, synaptic function and plasticity in the brain, but also as a target for the pathophysiology of a number
of neurological disorders. This article is part of a Special Issue entitled: Reciprocal inﬂuences between cell cyto-
skeleton and membrane channels, receptors and transporters. Guest Editor: Jean Claude Hervé.
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Ultrastructural studies of excitatory glutamatergic synapses in
the brain have revealed an electron-dense thickening in the postsyn-
aptic membrane termed the postsynaptic density (PSD). Over 1400
proteins, involving 133 neurological and psychiatric diseases, have
recently been identiﬁed in the human PSD [1]. Within the PSD, ainﬂuences between cell cytoskel-
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rights reserved.high concentration of glutamate receptors, associated signalling pro-
teins, and cytoskeletal elements are assembled by a number of syn-
aptic scaffold proteins [2–5]. The PSD stabilizes alpha-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs)
and N-methyl D-aspartate receptors' (NMDARs) opposite presynap-
tic terminals, providing the platform for synaptic transmission and
receptor movement in and out of the synaptic membrane during
synaptic plasticity [3–7]. Among these scaffolding proteins in the
PSD are the membrane-associated guanylate kinase homologs
(MAGUKs), a protein family that are proposed to be central control-
lers of multi-protein signalling complexes [8]. The MAGUK family, in-
cluding SAP97, PSD-95 (SAP90), PSD-93 (Chapsyn 110) and SAP102,
share a common domain organization with three N-terminal PDZ do-
mains, a Src-homology 3 (SH3) domain, and a carboxy terminal
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divergence among the MAGUK family members occurs within se-
quences between these core domains, especially those sequences at
the N-terminus before the ﬁrst PDZ domain, and between the SH3 and
GUK domains [8]. Each family member therefore plays distinct regula-
tory roles in the targeting, trafﬁcking and localisation of various mem-
brane channels [8].
In this review we will focus purely on SAP97. SAP97 is the rat ho-
mologue of the Drosophila and human discs large tumour suppressor
protein (hDlg). SAP97 contains the nucleotide and deduced amino
acid sequence of a 97 kDa protein. It is widely expressed throughout
the brain and in multiple organs, especially in epithelial cells in the
body [10–13]. SAP97 is enriched in excitatory synapses, where it is
strongly implicated in the trafﬁcking and localisation of both NMDA
and AMPA-type glutamate receptors, regulating synaptic plasticity
and could be involved in multiple neurological diseases.
2. SAP97 structure and alternative splicing
Like the other MAGUKs, SAP97 is composed of three PDZ (PSD-95,
Dlg, and ZO-1) repeats, a single SH3 domain, and an inactive GUK do-
main (Fig. 1). Additionally, SAP97 contains two regions of alternative
splicing. One region is at the N-terminus and the other region is locat-
ed between the SH3 and GUK domains (Fig. 1). In the N-terminal
region of SAP97 there are two spliced insertions, I1A and I1B, located
between the unique N-terminal domain of SAP97 and the ﬁrst PDZ re-
peat. The N-terminal alternatively spliced region of SAP97 can bind
SH3 domains from multiple proteins and also moderate SAP97
self-association [14]. The most prevalent isoform containing 1A, 1B,
and I3 is thought to recruit distinct SH3-containing proteins to the
sites of cell–cell contact, e.g. at synapses [14]. In addition to many in-
sertions, SAP97 contains alternative N-termini expressing either dou-
ble cysteines that normally are palmitoylated (αSAP97) or an L27
domain (βSAP97) (Fig. 1) [7,15,16]. The unique N-terminal domains
bestow distinct subsynaptic SAP97 localisation, targeting αSAP97 to
the PSD and βSAP97 primarily to perisynaptic regions [15]. βSAP97
has a longer N-terminal region featuring the L27 domain and is the
most prominent in the brain [16]. The region between the SH3 and
GUK domains of SAP97 contains four alternatively spliced insertions,
which have been characterised I2, I3, I4 and I5 [11,14].
The alternatively spliced insertions result in the existence of mul-
tiple alternatively spliced SAP97 isoforms. These endow SAP97 with
special functions but also result in the roles and functions of SAP97
being quite complicated to determine, especially when many earlier
studies did not deﬁne which isoform was being characterised. The
different intracellular distributions of SAP97 isoforms that have
been characterised in both neurons and epithelial cells likely reﬂect
their distinct functions within different cell types [14,17,18]. For
example, insertion I3 is responsible for the localisation of SAP97 to
the plasma membrane to the regions of cell–cell contact [14]. The I3
insert binds the actin/spectrin-associated protein, 4.1N, and this in-
teraction is thought to be critical for the synaptic targeting of SAP97
and AMPA receptors [17,19]. Deleting the SH3 or GUK domains does






Fig. 1. Schematic diagram of the domain organization of SAP97 isoforms. Illustrated are the m
domain (open rectangle) and a GUK domain (green rectangle). At the N-terminus are the
residues C3 and C5) and the latter an L27 domain. Alternatively spliced sequences (I1a, I1b
GUK domains.
Diagram modiﬁed from [15].region (ΔI3) that binds protein 4.1 reduces the targeting of SAP97
to spines [17]. The I2 insert does not bind protein 4.1 [11], and
SAP97I2 has a diffuse expression pattern in the soma and dendrites
of neurons with no localised concentration in dendritic spines [17].
The proposed role of the I2 insert is to target SAP97 to the nucleus
[17,20,21], although I2 variants have also been described at the cell
periphery and at the cell–cell contact points of differentiated cells
[17,20]. To date, very little is known about I2, I4 and I5 inserts in neu-
rons. All are known to be expressed in the brain [14] and in cultured
hippocampal neurons [17], but whether they play a major role in reg-
ulating glutamatergic receptors as has been shown for SAP97-I3-
containing isoforms remains to be determined.
3. SAP97 binding partners
SAP97 has been shown to interact with a number of binding part-
ners through its protein–protein interaction domains including mem-
brane ion channels and cytosolic structural proteins, and here we will
describe a few of these binding interactions. The ﬁrst identiﬁed bind-
ing partner of SAP97 was protein 4.1 [11,14], which as described
above interactswith the I3 insert/HOOKdomain of SAP97I3 situated be-
tween the SH3 and GUK domains. However, the unique N-terminus of
SAP97 plays a major role in selecting binding partners and in SAP97
localisation at adhesion sites, as well as the ion channel clustering
[22,23]. For example, the N terminus of SAP97 has a myosin VI binding
site, and direct binding betweenmyosin VI, SAP97 and the AMPA recep-
tor subunit, GluA1, trafﬁcs AMPA receptors in a trimeric complex to and
from the postsynaptic membrane [22]. SAP97 PDZ domains can directly
interact with KIF1Bα (kinesin family member 1Bα), and S-SCAM (syn-
aptic scaffolding molecule), forming protein complexes that may play
an important role in the axonal transport of a number of SAP97- and
S-SCAM-bound cargos, such as Kv1.4 potassium channel complexes
[24–26]. In addition to binding KIF1B, SAP97 can also bind through its
GUK domain to the microtubule-dependent motor KIF13B/GAKIN
(kinesin family member 13B) [8,18,27].
SAP97 also has intramolecular interactions that can regulate its
ability to bind other proteins. For example, the binding of GKAP
(GUK-associated protein) to the GUK domain of SAP97 is negatively
regulated by a series of intramolecular interactions between the
SH3 and GUK domains [28]. However, the N-terminal sequences
that precede PDZ1 facilitate GKAP binding through a U-shaped con-
formation state of SAP97. A unique feature of the existence of SAP97
in multiple conformations that depend on intramolecular interactions
is how this could subsequently alter SAP97 recruitment and assembly
at cell–cell contact sites in normal and disease states [27].
SAP97 also interacts with A-kinase-anchoring protein 79/150
(AKAP79/150) [29], a scaffold for PKA, PKC and the Ca2+/calmodulin
dependent protein phosphatase calcineurin (also known as PP2B).
This interaction is proposed to bring these kinases and phosphatases
close to their speciﬁc substrates at the synapse. For example, the
SAP97–AKAP complex facilitates the phosphorylation of the gluta-
mate receptor subunit GluA1 by PKA [29]. Therefore the SAP97–
AKAP79 complex might be important for the recruitment of kinases
and phosphatases to synaptic AMPARs. Phosphorylation of SAP97 byDZ PDZ SH3 GUK
I3 I2 I4 I5
ajor protein–protein interaction sites of SAP97: three PDZ domains (red ovals), an SH3
α- and β-isoform inserts, with the former containing a palmitoylation motif (cysteine
, I2, I3, I4 and I5) are indicated at the N-terminus (I1a, I1b) and between the SH3 and
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SAP97, and of its binding partner GluA1 [30]. The L27 domain is
involved in SAP97 heteromultimerization and homomultimerization
with itself and other L27 domain-containing proteins, such as
calmodulin-dependent serine protein kinase (CASK) [31]. CASK
requires an L27 domain-mediated interaction to associate with the
SAP97/NMDAR complex in hippocampal neurons [32]. Thus, L27 do-
mains appear to play a central role in the higher order organization
of multi-scaffold assemblies [33].
By far the majority of research that has examined the binding
interactions of SAP97 has focused on its role in targetting and trafﬁck-
ing ion channel complexes. The major binding partners of SAP97 are
AMPA and NMDA-type glutamate receptors, and K+ channels [8].
These ion channels play major roles in regulating neuronal excitabil-
ity, synaptic transmission and plasticity, and thus their targetting by
SAP97 is of upmost importance for normal brain function.
4. SAP97 and AMPARs
MAGUKs generally interact with AMPARs in the PSD through
AMPAR auxiliary subunits known as transmembrane AMPAR regula-
tory proteins (TARPs) [6,34]. SAP97 is the only member of the
MAGUK family to interact directly with the AMPAR subunit GluA1
[35]. Because the recruitment of GluA1 is a critical step for inducing
and maintaining forms of synaptic plasticity such as long-term poten-
tiation (LTP), the interaction between GluA1 and SAP97 is one of the
most interesting topics for many investigators to study MAGUKs in
regulating AMPARs in synaptic plasticity. SAP97 directs GluA1 for-
ward trafﬁcking from the Golgi network to the plasma membrane.
The minus-end directed actin-based motor, myosin VI and SAP97
are thought to form a trimeric complex with GluA1, with SAP97 act-
ing as a molecular link between GluA1 and myosin VI to transport
AMPA receptors to the postsynaptic plasma membrane [22].
However, the role of SAP97 in the trafﬁcking and synaptic location
of AMPARs is far from solved with multiple labs reporting different
data. Early work showed that SAP97 only interacts with GluA1 early
in the secretory pathway during its forward trafﬁcking to the plasma
membrane, suggesting that SAP97 acts on GluA1 solely before its syn-
aptic insertion and that it does not play a major role in anchoring
AMPARs at synapses [36]. Overexpression of βSAP97 was found to en-
hance the amplitude of AMPAR-mediated currents [6,37], rescue
AMPAR currents reduced by RNAi-mediated knockdown of PSD-95
[16] and change the paired pulse ratio, indicating a change in presyn-
aptic release probability through trans-synaptic signalling [6].
Expression of SAP97I3 also enlarges spines and increases mEPSC fre-
quency [17]. Other studies indicated that overexpression of βSAP97
did not change AMPAR currents and loss of SAP97 did not change
AMPAR EPSCs either [13,16,38,39]. Recently, overexpression of
palmitoylated αSAP97I3 has been shown to promote synaptic
strengthening by localising primarily in the PSD where it selectively
regulates the synaptic pool of AMPA receptors [7,15]. In contrast,
the L27-domain containing βSAP97I3 has been shown to selectively
regulate the extrasynaptic pools of both AMPA and NMDA receptors
and prevent NMDA receptor-dependent LTP [7]. Therefore N-terminal
SAP97 isoforms appear to be able to regulate the ability to undergo plas-
ticity by differentially controlling surface receptor distribution.
These contradictory data may be in part due to earlier studies not
deﬁning which splice isoforms of SAP97 were being characterised, or
only describing one splice site insert between the SH3 and GUK
domains but not other N-terminal splice inserts. The use of different ex-
perimental preparations and expression levels of SAP97 isoforms be-
tween studies also prevents direct comparisons. In addition, like other
PSD-MAGUKs, SAP97 may be sufﬁcient but not solely necessary for
the trafﬁcking of AMPARs to synapses [6,40]. Transgenicmice have pro-
vided limited insights into this as mice harbouring a truncation of
SAP97 do not survive beyond birth because craniofacial deformitiesprevent feeding [41]. However, neurons grown in vitro from SAP97mu-
tant embryos develop normally and form synapses with normal levels
of AMPAR subunits [13,16]. These ﬁndings raise the possibility that
MAGUK family members share redundant functions in neurons and
the loss of one can be partially compensated by other MAGUKs [16].
5. SAP97 and NMDARs
SAP97 is also implicated in targeting and trafﬁcking NMDA recep-
tor at synapses. Like other PSD-MAGUKs, SAP97 interacts directly via
its PDZ domains with NMDAR PDZ-binding motifs [6,42]. SAP97 plays
a role in regulating NMDA receptors through the GluN2A/2B subunits
[43,44]. SAP97 directly associates with the GluN2A subunit of the
NMDAR through its PDZ1 domain in a CaMKII regulated manner.
CaMKII phosphorylates SAP97 on two major sites, Ser39 located in
the N-terminal domain and Ser232 located in PDZ1 domain. CaMKII
phosphorylation of SAP97-Ser39 releases the SAP97–GluN2A com-
plex from the endoplasmic reticulum to drive SAP97 to the postsyn-
aptic region [43]. NMDAR activation induces CaMKII-dependent
phosphorylation of SAP97-Ser232 to disrupt the SAP97–GluN2A in-
teraction [45]. Thus, CaMKII-dependent phosphorylation of SAP97
controls both GluN2A trafﬁcking and insertion at synapses [43].
SAP97 is also important for the targeting of NMDARs to dendritic
spines in hippocampal neurons. A novel secretory pathway for
NMDAR trafﬁcking requiring SAP97 has been described [32]:
βSAP97 and CASK are required for the sorting of NMDARs from
AMPARs in the somatic ER, causing a majority of NMDARs to bypass
somatic Golgi and trafﬁc via dendritic Golgi outposts to synapses
[32]. When this alternative pathway is unavailable, NMDARs can traf-
ﬁc to synapses via the conventional secretory pathway, as evidenced
by the accumulation of NMDARs in somatic Golgi during the knock-
down of βSAP97 or CASK. Intriguingly, SAP97 only appears to utilise
the Golgi outpost secretory pathway when in a complex with
NMDARs, as it does not trafﬁc with AMPARs through this novel path-
way [32]. This trafﬁcking pathway could allow NMDARs to be more
efﬁciently targeted to synapses and may also enable local regulation
of NMDAR insertion near to synaptic sites (Fig. 2).
In immature neurons, SAP97 preferentially interacts with GluN2A
compared with GluN2B, and overexpression of SAP97 during early
development can increase synaptic NMDAR number [6]. In utero,
overexpression of SAP97 can drive the developmental NMDAR
subunit switch, inducing larger NMDAR current amplitudes and faster
NMDAR current kinetics. These data indicate a potential role for
SAP97 in controlling both the number, the subunit composition and
consequently the channel kinetics of synaptic NMDARs [6].
Similar to studies on SAP97 and AMPARs, multiple studies have
examined the role of SAP97 in regulating synaptic NMDARs
(e.g. [6,7,16,37]). Again, conﬂicting data has been produced on the ef-
fects of βSAP97 and its deletion or knockdown on NMDAR-mediated
currents. The complex splicing of SAP97 at multiple sites likely under-
lies these differing results, particularly the I3/I4/I5 splice inserts which
have not been independently characterised in neurons, and it is not
clear which of these inserts were present in all studies. Targeted knock-
downofβSAP97 alone has shown that in the absence ofβSAP97, synaptic
AMPARs and NMDARs are increasedwhereas extrasynaptic receptors are
decreased. This suggests that a major role of endogenous βSAP97 is to
exclude receptors from the synapse and negatively regulate synaptic
plasticity [7]. Deletion of all SAP97 isoforms revealed that glutamatergic
synaptic transmission and LTPwere normal inmature neurons [6]. There-
fore, the roles of SAP97 isoforms in regulating NMDAR-dependent func-
tions can be compensated by other PSD-MAGUKs.
6. SAP97 and potassium channels
In addition to the multiple roles of SAP97 in binding potassium
and sodium channel subtypes in cardiac cells to regulate cardiac
Fig. 2. Model of the alternative secretory pathway in neurons through which SAP97 trafﬁcs with NMDA receptors. SAP97, CASK and NMDA receptors are proposed to exit the en-
doplasmic reticulum and bypass the ERGIC pathway. The SAP97/CASK/NMDA receptor complex travels along dendrites in mobile ER-derived vesicles. NMDARs are then inserted
into synapses via Golgi outposts. Blocking trans-Golgi network exit via ARF-Q71I block fails to prevent NMDAR but not AMPAR trafﬁcking to synapses, however downregulation
of SAP97 or CASK reduces synaptic NMDARs. SAP97 is therefore thought to associate with NMDARs during and/or after their assembly in the ER and this interaction prevents
their ability to transit from ER exit sites to the somatic Golgi.
Diagram is from [32].
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plays a major role in directing the trafﬁcking, localisation and anchor-
ing of potassium channels in neurons. Voltage-gated potassium
channels (Kv channels) were ﬁrst discovered in electrophysiological
experiments carried out in squid axons [49]. Later, in Drosophila, elec-
trical recordings from the Shaker mutant produced a unique pheno-
type at the neuromuscular junction that could be mimicked with a
potassium channel blocker [50]. It was later shown that the Shaker
gene encodes several voltage-gated potassium channel α-subunits
[51]. There are twelve families of Kv channels (Kv1–12) and their di-
versity arises from the fact that Kv channels may be homotetramers
or heterotetramers of different subunits within the same family
[52]. Their function is diverse and includes maintaining membrane
potential and modulating electrical excitability in neurons and muscle.
Another type of potassium channel, inwardly rectifying potassium
(Kir) channels, consists of seven Kir subfamilies, Kir1–7 [53]. Inwardly
rectifying potassium (Kir) channels are characterised by their large
inward currents at potentials negative to the potassium equilibrium po-
tential and small outward currents at potentials that are more positive.
Kir channels are also important in maintaining resting membrane po-
tential, repolarisation of the action potential and mediating cell excit-
ability. Both Kv and Kir channels have been shown to be associated
with SAP97, which mediates channel localisation and trafﬁcking.
Binding of Kv channels (like NMDA receptors) is mediated by their
C-terminal tail binding to the PDZ1 and PDZ2 domains in the
N-terminus of SAP97 and PSD95 [54]. Both SAP97 and PSD95 bind
Shaker-type voltage-gated K+ channel subunits (Kv1) with high afﬁn-
ity and also mediate their clustering [24,54]. Evidence for a SAP97/Kv1
interaction comes from COS cells where co-immunoprecipitation stud-
ies have shown that Kv1.4 antibodies co-immunoprecipitate SAP97
with Kv1.4 and similarly SAP97 antibodies co-immunoprecipitate
SAP97 with Kv1.4 [24]. Also, the co-transfection of SAP97 and Kv1.4 in
COS cells results in their colocalisation via a direct interaction between
the C-terminus of the Kv1.4 channel and SAP97 and leads speciﬁcally to
their cytoplasmic distribution [24,25].
Interestingly, the efﬁciency of the interaction between SAP97 and
Kv1 subunits does not correlatewith channel surface expression efﬁcien-
cy (unlikewith PSD95) in COS cells [25]. For example, the SAP97 cluster-
ing efﬁciency is very similar for Kv1.1, Kv1.2 andKv1.2 + Kvβ2 channelsbut these channels have dramatically different cell surface expression ef-
ﬁciencies. Further analysis showed that as well as increasing the cyto-
plasmic distribution of the Kv1 channel, SAP97/Kv1 clustering also
dramatically reduces the surface expression of these channels [25]. The
clustering efﬁciency of SAP97 with Kv1 channels closely reﬂects the
magnitude of decrease in cell surface expression, indicating that this in-
teractionwith SAP97 leads to the intracellular retention of Kv1 channels.
Furthermore, immunostaining for ER proteins showed that SAP97 re-
tains Kv1.4 channels in an ER derived compartment speciﬁcally [25].
A more recent ﬁnding is that SAP97 directs Kv4.2 to spines in hip-
pocampal neurons [55]. Kv4.2 is a key component of the A-type po-
tassium channel, which is involved in dendritic excitability and
plasticity. Firstly, subcellular fractionation in hippocampal cultured
neurons has shown that the Kv4.2 channel is enriched in the PSD frac-
tion, the total homogenate and in the crude membrane fraction but
has low expression levels in the synaptosomal membrane and cyto-
solic fraction [55]. This pattern is similar to that of SAP97 and
SAP102. As shown in the COS cells, co-immunoprecipitation in hippo-
campal neurons shows that Kv4.2 co-precipitates with SAP97 and this
occurs in all subcellular fractions [55]. Similar results are obtained in
cultured organotypic slices virally infected with SAP97 and Kv4.2 [55].
In cultured hippocampal neurons SAP97 is responsible for the trafﬁck-
ing of Kv4.2 channels to synaptic sites as SAP97 knockdown (using
RNAi) decreases Kv4.2 localisation in the PSD enriched fraction [55].
It is also known that both Kv4.2 and SAP97 are substrates for
CAMKII in hippocampal neurons [45,56]. Speciﬁcally, CAMKII depen-
dent phosphorylation of SAP97 Ser39 regulates the localisation of
SAP97 as well as SAP97 interacting proteins [30,45]. Interestingly,
CAMKII phosphorylation of SAP97 (Ser39) does not affect SAP97 clus-
tering with Kv4.2 but causes a redistribution of Kv4.2 channels from
internal compartments towards the cell surface in both hippocampal
neurons and COS cells [55]. In the hippocampal neurons Ser39 phos-
phorylated SAP97 increases Kv4.2 channels in spine-like structures
and in dendrites [55]. Therefore, CAMKII phosphorylation of SAP97
Ser39 is involved in the synaptic trafﬁcking of Kv4.2.
Similarly the interaction between SAP97 and Kv4.2 channels has
also been demonstrated in the heart. The voltage-dependent Kv4.2
and Kv4.3 channels are one of the major regulators of the transient
outward potassium current in the heart, which regulates cardiac
593C. Fourie et al. / Biochimica et Biophysica Acta 1838 (2014) 589–594cycle length [57,58]. In the heart SAP97 has been shown to interact
with Kv4 channels in pull-down assays and to colocalise with these
channels in immunocytochemistry experiments [59]. In Chinese ham-
ster ovary cell lines, SAP97 was speciﬁcally necessary for the CaMKII
regulation of Kv4.3 channels as well as for the clustering of Kv4.3
channels [59]. Therefore SAP97 regulates the transient outward po-
tassium current in the heart by interacting with Kv4 channels.
Furthermore, in rat cerebellum and heart, it has been shown that
SAP97 forms interactions with Kir2.1, Kir2.2 and Kir2.3 and that the
second PDZ domain of SAP97 is sufﬁcient for the interaction with
Kir2.2 [60,61]. These Kir channels as well as Kir4.1 bind to SAP97
and CASK with different afﬁnities as shown in afﬁnity pull down
experiments [60]. Furthermore, co-immunoprecipitation has shown
that Kir2.2 is associated with SAP97 in both rat cerebellum and
heart and that phosphorylation of the Kir2.2 C-terminus by PKA
inhibits this interaction with SAP97 [61]. Altogether, SAP97 associates
with both Kv and Kir channels to regulate their trafﬁcking and
localisation, ultimately affecting cell function, excitability and cell–
cell communications.
7. Conclusions and future directions
The complex roles of SAP97 in targeting and regulating ion chan-
nels in neurons is far from completely understood, and future studies
that decipher the differential roles that each isoform plays will be
important in our understanding of neuronal excitability, synapse
function and plasticity. Whether SAP97 isoforms work in tandem or
alone remains to be determined. Moreover, a role for SAP97 has
been raised in numerous brain diseases including schizophrenia
[62], Alzheimer's Disease [63], Parkinson's disease [64] and epilepsy
[65]. Although glutamate receptor targets are attractive candidates
for therapeutic intervention, the critical roles of these receptors in
many brain processes produced serious side effects. Should each
SAP97 isoform prove to display independent functional roles, each
could serve as individual targets in the development of pathophysiol-
ogy or treatments of a number of these diseases in which neuronal
excitability and/or glutamatergic synaptic transmission are altered.
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